3 nominees · 4 ballot items.
Elect three Class I directors; ratify Ernst & Young LLP as independent auditors; advisory vote on frequency of future say-on-pay votes (one year recommended); and advisory approval of named executive officer compensation (say-on-pay).
Elect Michael D. Schoeb, Phyllis A. Knight and Robert L. Verigan as Class I directors to serve until the 2029 annual meeting.
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Non-binding advisory vote to indicate whether future advisory votes on executive compensation should occur every 1, 2 or 3 years (Board recommends ONE YEAR).
This non‑binding management proposal asks stockholders to indicate whether future say‑on‑pay advisory votes should occur every one, two, or three years (or to abstain). Management recommends an annual vote, arguing that yearly advisory votes give stockholders more timely input on executive compensation, enhance engagement, and allow the Board and Compensation Committee to receive regular feedback on the Company’s pay philosophy and practices. The proposal is required by Dodd‑Frank and Rule 14a‑21 and is advisory only, so the Board retains discretion but commits to consider stockholder preferences. The Board’s rationale emphasizes fostering consistent dialogue with investors and ensuring that compensation disclosures and practices are subject to frequent review. An annual vote may increase administrative burden but provides more immediate market signal that can influence pay decisions and improvements. Conversely, multi‑year cycles are sometimes argued to reduce short‑termism and lower administrative costs; the Company notes stockholders may have differing views. The recommendation for annual votes aligns with Alliance Laundry’s emphasis on investor engagement and the use of an Adjusted EBITDA metric in incentive pay, where frequent feedback can be relevant as strategy and performance evolve. Institutional investors often prefer annual say‑on‑pay votes; the outcome will inform future governance and compensation adjustments though not bind the Board.
Non‑binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement (Board recommends FOR).
This advisory (non‑binding) say‑on‑pay proposal requests stockholder approval of the overall compensation of the Company’s named executive officers as disclosed in the proxy statement. Management presents this vote to provide investors an opportunity to express their views on pay‑for‑performance alignment; the Compensation Committee emphasizes its use of market benchmarking, an independent adviser (Aon), a mix of base salary, Adjusted EBITDA‑linked annual cash incentives, and long‑term equity (RSUs and options) to align executives with stockholder interests. The Board underscores that the Metric Bonus Plan ties annual incentives to Adjusted EBITDA with threshold, target and maximum payout levels and that long‑term awards were transitioned in connection with the IPO to RSUs with multi‑year vesting to encourage retention and long‑term value creation. The proposal is advisory and non‑binding, but the Board and Compensation Committee commit to consider the vote outcome in future compensation decisions and to maintain engagement with stockholders. The Company describes governance safeguards including clawback policy, stock ownership guidelines, independent compensation consultant review, and committee oversight to mitigate excessive risk-taking. Given the Company’s controlled‑company status and recent IPO, the vote also serves as an investor governance signal on the transition to public‑company compensation norms. The Board’s unanimous recommendation for a FOR vote reflects its view that the disclosed program appropriately balances retention, performance incentives, and alignment with stockholder interests.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BDT CAPITAL PARTNERS, LLC | 70.9% | 140,751,696 | $2.9B |
| 2 | Capital International Investors | 3.7% | 7,302,367 | $151M |
| 3 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 2.8% | 5,478,416 | $114M |
| 4 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 2.0% | 3,978,438 | $83M |
| 5 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.0% | 2,045,200 | $42M |
| 6 | T. Rowe Price Investment Management, Inc. | 1.0% | 2,023,841 | $42M |
| 7 | WELLINGTON MANAGEMENT GROUP LLP | 1.0% | 1,894,266 | $39M |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 0.9% | 1,738,080 | $36M |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 0.9% | 1,721,962 | $36M |
| 10 | JPMORGAN CHASE CO | 0.8% | 1,637,991 | $32M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.